Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership. Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite. It is a novel technique which is...
The theoretical – practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad! III Edición Curso Práctico en STUI y Patología Vesicoprostática basado en...
EchoLaser is a multichannel laser system used for the ultrasound or fusionguided laser ablation of both benign and malignant lesions in the prostate, such as Benign Prostatic Hyperplasia and localized Prostate Cancer. EchoLaser was developed by the Italian Med-Tech...
The echolaser phenomenon for the treatment of benign prostatic hyperplasia is spreading without limits. TPLA is increasingly being used among professionals with enormous satisfaction. Is the turn of the hospital paolo borsellino of Marsala with Dr. Emanuele Caldarera...
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy. AcceptRead the policy
